Purdue Says Collegium's Nucynta Sales Infringe 3 Patents
Purdue Pharma LP on Wednesday accused Collegium NF LLC in Delaware federal court of infringing three of its patents covering a gelling agent when it started selling formulations of the opioid...To view the full article, register now.
Already a subscriber? Click here to view full article